Lack of antidiabetic effect of a Eugenia jambolana leaf decoction on rat streptozotocin diabetes

Brazilian Journal of Medical and Biological Research

Volumn 34, Issue 3, 2001, Pages 389-395

  Pepato, M T ^a   Folgado, V B B ^a   Kettelhut, I C ^b   Brunetti, I L ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antidiabetic plant; Diabetic rats; Eugenia jambolana; Hyperglycemia

Indexed keywords

ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; SYZYGIUM CUMINI EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; WATER;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; EUGENIA JAMBOLANA; FLUID INTAKE; FOOD; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HYPERGLYCEMIA; MUSCLE TISSUE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; URINE VOLUME;

ANIMALIA; EUGENIA; MYRTACEAE; SYZYGIUM CUMINI;

EID: 0035066097     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2001000300014     Document Type: Article

References (34)

1. Elisabetsky E (1987). Pesquisas em plantas medicinais. Ciência e Cultura, 39: 697-702.
2. Teixeira CC, Pinto LP, Kessler FHP, Knijnik L, Pinto CP, Gastaldo GJ & Fuchs FD (1997). The effect of Syzygium cumini (L.) skeels on post-prandial blood glucose levels in non-diabetic rats and rats with streptozotocin-induced diabetes mellitus. Journal of Ethnopharmacology, 56: 209-213.
3. Consolini AE, Baldini OAN & Amat AG (1999). Pharmacological basis for the empirical use of Eugenia unifiora L. (Myrtaceae) as antihypertensive. Journal of Ethnopharmacology, 66: 33-39.
4. Arruda LFMR, Freitas ACS, Granjeiro OP, Aquino EG & Martins MF (1984). Estudo dos efeitos farmacológicos induzidos pelo extrato aquoso de razes de Eugenia punissifolia (HBK) DC. VIII Symposium on Brazilian Medicinal Plants, Manaus, AM, Brazil, May 11-16.
5. Teixeira CC, Fuchs FD, Blotta RM, Knijnik J, Delgado IC, Netto MS, Ferreira E, Costa AP, Mussnich DG, Ranquetat GG & Gastaldo G (1990). Effect of tea prepared from leaves of Syzygium jambos on glucose tolerance in nondiabetic subjects. Diabetes Care, 13: 907-908.
6. Index Kewensis (1960). Plantarum phanerogamarum nomina et Synonyma omnium generum et specerum a Linnaeo usque ad annum 1895 complectens. Clarendon Press, Oxford, 2: 1027 (Abstract).
7. Schmeda-Hirschmann G, Theoduloz C, Franco L, Ferro E & de Arias AR (1987). Preliminary pharmacological studies on Eugenia uniflora leaves: xanthine oxidase inhibitory activity. Journal of Ethnopharmacology. 21: 183-186.
8. Schmeda-Hirschmann G (1988). Ethnobotanical observations on Paraguayan Myrtaceae. Journal of Ethnopharmacology, 22: 73-79.
9. Amat AG & Yajía ME (1991). Medicinal plants and ethnopharmacology in the province of Misiones (Argentina). Acta Farmacéutica Bonaerense, 10: 153-159.
10. Arai I, Amagaya S, Komatsu Y, Okada M, Hayashi T, Kasai M, Ansawa M & Momose Y (1999). Improving effects of the extracts from Eugenia uniflora on hyperglycemia and hypertriglyceridemia in mice. Journal of Ethnopharmacology, 68: 307-314.
11. Romero MJ (1995). Acción cardiovascular de extractos acuosos de hojas de Syzygium jambos (L.) Alston. Revista Costarricence de Ciências Médicas, 16: 17-25.
12. Silva Neto CR, Lopes RA & Pozetti GL (1986). Efeitos do extrato de folhas secas de jambolão (Syzygium jambolanum) sobre a excreçāo renal de água, sódio e potássio em ratos. Resultados preliminares. Revista da Faculdade de Odontologia de Ribeirâo Preto, 23: 213-215.
13. Silva Neto CR, Lopes RA & Pozetti GL (1989). Utilizaçāo de extrato de botão floral de jambolāo (Syzygium jambolanum) na excreçāo renal de água e eletrólitos em ratos. Pesquisa Homeopatica, 4: 15-21.
14. Mukherjee PK, Saha K, Murugesan T, Mandal SC, Pal M & Saha BP (1997). Screening of anti-diarrhoeal profile of some plant extracts of a specific region of West Bengal, India. Journal of Ethnopharmacology, 60: 85-89.
15. Kusumoto IT, Nakabayashi T, Kida H, Miyashiro H, Hattori M, Namba T & Shimotohno K (1995). Screening of various plant extracts used in ayuvedic medicine for inhibitory effects on human immunodeficiency virus type 1 (HIV-1) protease. Phytotherapy Research, 9: 180-184.
16. De Lima TCM, Klueger PA, Pereira PA, Macedo-Neto WP, Morato GS & Farias MR (1998). Behavioural effects of crude and semi-purified extracts of Syzygium cumini Linn. skeels. Phytotherapy Research, 12: 488-493.
17. Ratsimamanga AR, Loiseau A, Ratsimamanga-Urverg S & Bibal-Prot P (1973). Nouvelle contribution à l'étude de l'action d'un principe hypoglycémiant mis en évidence dans d'écorce jeune de Eugenia jambolana (Myrtacées) sur l'hyperglicémie provoquée du lapin normal et pursuite de sa purification. Comptes Rendus Hebdomadaires des Séances de l'Académie des Sciences. Serie D, Sciences Naturelles, 277: 2219-2222.
18. Kedar P & Chakrabarti CH (1983). Effects of jambolan seed treatment on blood sugar, lipids and urea in streptozotocin induced diabetes in rabbits. Indian Journal of Physiology and Pharmacology, 27: 135-140.
19. Prince PS, Menon VP & Pari L (1998). Hypoglycaemic activity of Syzygium cumini seeds: effect on lipid peroxidation in alloxan diabetic rats. Journal of Ethnopharmacology, 61: 1-7.
20. Sigogneau-Jagodzinski M, Bibal-Prot P, Chanez M, Boiteau P & Rakoto A (1967). Contribution à l'étude de l'activité hypoglycémiante et antidiabétique d'un principe extrait du Totra de Madagascar (Eugenia jambolana Lamarck). Comptes Rendus de l'Académie des Sciences, 264: 1119-1123.
21. Achrekar S, Kaklij GS, Pote MS & Kelkar SM (1991). Hypoglycemic activity of Eugenia jambolana and Ficus bengalensis: mechanism of action. In Vivo, 5: 143-147.
22. Petenusci SO, Lopes RA, Sala MA, Pozetti GL, Bernardi AC & Cabrera A (1986). Estudio de la acion hipoglicemiante de las hojas de yambo (Syzygium jambolanum) en ratas com diabetes aloxanica. Ars Pharmaceutica, XXVII: 193-196.
23. Teixeira CC, Rava CA, Da Silva PM, Melchior R, Argenta R, Anselmi F, Almeida CRC & Fuchs FD (2000). Absence of antihyperglycemic effect of jambolan in experimental and clinical models. Journal of Ethnopharmacology, 71: 343-347.
24. Pepato MT, Migliorini RH, Goldberg AL & Kettelhut IC (1996). Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats American Journal of Physiology, 271: E340-E347.
25. Duboswski KM !1962). An o-toluidine method for body fluid glucose determination. Clinical Chemistry, 9: 215-235.
26. Wibenga DR, Di Giorgio JE & Pileggi VJ (1971). Manual and automated methods for urea nitrogen measurement in whole serum. Clinical Chemistry. 17: 891-895.
27. Groff JL, Harp JB & DiGirolamo M (1993). Simplified enzymatic assay of angiotensin-converting enzyme in serum. Clinical Chemistry, 39: 400-404.
28. Evans WC (1996). Commerce and production: principles related to the commercial production, quality and standardization of natural products. In: Trease GE & Evans WC (Editors), Pharmacognosy. 14th edn. Saunders, London.
29. Chirvan-Nia MMP & Ratsimamanga AR (1972). Régression de la cataracte et de l' hyperglycémie chez le rat des sables (Psammomys obesus) diabétique ayant reçu un extrait de Eugenia jambolana (Lamarck). Comptes Rendus Hebdomadaires des Séances de l'Académie des Sciences. Serie D, Sciences Naturelles, 274: 254-257.
30. Pepato MT, Oliveira JR, Kettelhut IC & Migliorini RH (1993). Assessment of the antidiabetic activity of Myrcia uniflora extracts in streptozotocin-uiabetic rats. Diabetes Research, 22: 49-57.
31. Vranes D, Dilley RJ & Cooper ME (1995). Vascular changes in the diabetic kidney: effects of ACE inhibition. Journal of Diabetes and its Complications, 9: 296-300.
32. Valentovic MA, Elliott CM & Ball JG (1987). The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme activity Research Communications in Chemical Pathology and Pharmacology, 58: 27-39.
33. Erman A, Chen-gal B, David I, Giler S, Boner G & Van Dijk DJ (1998). Insulin treatment reduces the increased serum and lung angiotensin converting enzyme activity in streptozotocin-induced diabetic rats. Scandinavian Journal of Clinical and Laboratory Investigation, 58: 81-87.
34. Gilbert RE, Cox A, Wu II, Allen TJ, Hulthen UI, Jerums G & Cooper ME (1998). Expression of transforming growth factor-beta and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. Diabetes, 47: 414-422.